NADAC acquisition cost data for ALYACEN 1-35 28 TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 68462039429 | $0.3151 | 2022-12-21 | Rx |
| 68462039484 | $0.3151 | 2022-12-21 | Rx |
| 68462039429 | $0.3151 | 2022-12-21 | Rx |
| 68462039484 | $0.3151 | 2022-12-21 | Rx |
Generic: Norethindrone-Ethin. Estradiol | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $160.8K | 5,349 | 1,243 | $0.6532 |
| 2020 | $189.2K | 6,066 | 1,303 | $0.6590 |
| 2021 | $199.9K | 6,501 | 1,384 | $0.6614 |
| 2022 | $179.2K | 5,717 | 1,170 | $0.6720 |
| 2023 | $143.4K | 4,665 | 1,056 | $0.6230 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| Massachusetts | $10.4K | 258 | 74 |
| California | $10.4K | 314 | 81 |
| Illinois | $8.7K | 370 | 62 |
| Ohio | $7.7K | 249 | 58 |
| Pennsylvania | $7.0K | 198 | 58 |
| New York | $6.9K | 216 | 55 |
| Michigan | $6.2K | 199 | 48 |
| Washington | $6.0K | 197 | 45 |
| North Carolina | $5.6K | 147 | 36 |
| Missouri | $5.6K | 154 | 41 |
| Tennessee | $5.1K | 169 | 31 |
| Wisconsin | $4.6K | 176 | 37 |
| Minnesota | $4.2K | 99 | 24 |
| Indiana | $4.0K | 156 | 36 |
| Georgia | $3.2K | 108 | 22 |
| Texas | $3.2K | 103 | 24 |
| Virginia | $3.0K | 92 | 24 |
| Kentucky | $2.7K | 108 | 18 |
| Oregon | $2.7K | 115 | 22 |
| New Jersey | $2.7K | 87 | 20 |
| Iowa | $2.4K | 96 | 21 |
| South Carolina | $2.3K | 71 | 20 |
| Florida | $2.3K | 81 | 25 |
| Alabama | $1.9K | 51 | 11 |
| South Dakota | $1.9K | 85 | 12 |
| Connecticut | $1.8K | 69 | 15 |
| Oklahoma | $1.6K | 34 | N/A |
| Louisiana | $1.6K | 81 | 11 |
| Kansas | $1.5K | 63 | N/A |
| Maryland | $1.5K | 52 | 15 |
| Arizona | $1.4K | 35 | 11 |
| Nebraska | $1.4K | 43 | N/A |
| Arkansas | $1.3K | 49 | N/A |
| Maine | $1.3K | 31 | 11 |
| Utah | $1.3K | 69 | N/A |
| New Hampshire | $1.1K | 28 | N/A |
| Rhode Island | $1.0K | 32 | N/A |
| North Dakota | $949.43 | 16 | N/A |
| Mississippi | $896.12 | 34 | N/A |
| Idaho | $646.20 | 28 | N/A |
| Delaware | $609.66 | 29 | N/A |
| Vermont | $561.94 | 21 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.